Rut Klinger

1.1k total citations
14 papers, 502 citations indexed

About

Rut Klinger is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rut Klinger has authored 14 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Rut Klinger's work include Cancer Genomics and Diagnostics (4 papers), Cancer Research and Treatments (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Rut Klinger is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Research and Treatments (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Rut Klinger collaborates with scholars based in Ireland, Sweden and United Kingdom. Rut Klinger's co-authors include Darran P. O’Connor, William M. Gallagher, Helen M. Roche, Juan F. Alcalá‐Díaz, Orla M. Finucane, Fiona C. McGillicuddy, Rebecca C. Coll, Kanishka N. Nilaweera, M. O'Reilly and Aoife A. Cooke and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Diabetes.

In The Last Decade

Rut Klinger

14 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rut Klinger Ireland 8 263 103 98 94 92 14 502
Fuwen Luo China 13 323 1.2× 173 1.7× 41 0.4× 63 0.7× 88 1.0× 26 647
Lei Gong China 15 378 1.4× 158 1.5× 67 0.7× 70 0.7× 129 1.4× 45 700
Yuan Liang China 13 281 1.1× 65 0.6× 34 0.3× 79 0.8× 104 1.1× 22 539
Haizhao Yan China 12 265 1.0× 66 0.6× 40 0.4× 60 0.6× 92 1.0× 28 551
Ryusei Uchio Japan 8 151 0.6× 95 0.9× 35 0.4× 44 0.5× 55 0.6× 11 401
Xiumei Zheng China 10 229 0.9× 171 1.7× 45 0.5× 88 0.9× 167 1.8× 25 533
Kazem Mashayekhi Iran 12 212 0.8× 57 0.6× 59 0.6× 61 0.6× 76 0.8× 26 623
Qinghai Li China 16 253 1.0× 119 1.2× 39 0.4× 67 0.7× 114 1.2× 35 615
Meredith S. Carson United States 11 265 1.0× 114 1.1× 154 1.6× 143 1.5× 69 0.8× 15 556
Nina Grossmann Germany 8 340 1.3× 101 1.0× 52 0.5× 58 0.6× 69 0.8× 9 622

Countries citing papers authored by Rut Klinger

Since Specialization
Citations

This map shows the geographic impact of Rut Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rut Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rut Klinger more than expected).

Fields of papers citing papers by Rut Klinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rut Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rut Klinger. The network helps show where Rut Klinger may publish in the future.

Co-authorship network of co-authors of Rut Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of Rut Klinger. A scholar is included among the top collaborators of Rut Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rut Klinger. Rut Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Brennan, Donal J., Sudipto Das, Bruce Moran, et al.. (2019). Abstract 5033: The role of the epigenetic regulator SATB2 in colon cancer progression. Cancer Research. 79(13_Supplement). 5033–5033. 1 indexed citations
2.
O’Connor, Darran P., Donal J. Brennan, Sudipto Das, et al.. (2018). SATB2 loss and the immune milieu of colorectal cancer (CRC).. Journal of Clinical Oncology. 36(15_suppl). 3569–3569. 1 indexed citations
3.
Das, Sudipto, Rut Klinger, Yue Fan, et al.. (2018). Abstract 698: The loss of SATB2 promotes ulcerative colitis-related colon cancer progression through altered localized inflammatory response. Cancer Research. 78(13_Supplement). 698–698. 1 indexed citations
4.
Synnott, Naoise C., Matthias R. Bauer, Stephen F. Madden, et al.. (2017). Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007. Cancer Letters. 414. 99–106. 58 indexed citations
5.
Madden, Stephen F., Naoise C. Synnott, Rut Klinger, et al.. (2017). Vitamin D receptor as a target for breast cancer therapy. Endocrine Related Cancer. 24(4). 181–195. 45 indexed citations
6.
Synnott, Naoise C., Matthias R. Bauer, Stephen F. Madden, et al.. (2017). Targeting mutant p53 with PK11007: A new approach for the treatment of patients with triple-negative breast cancer?. Journal of Clinical Oncology. 35(15_suppl). e14099–e14099. 4 indexed citations
7.
Moran, Bruce, Sudipto Das, Dominiek Smeets, et al.. (2017). Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach. Oncotarget. 8(29). 48126–48137. 12 indexed citations
8.
Byrne, Annette T., Dominiek Smeets, Ian S. Miller, et al.. (2017). Identification of a novel predictive genomic biomarker for response to combination bevacizumab in metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 35(15_suppl). 3580–3580. 1 indexed citations
9.
Kenny, Colin, Rut Klinger, Darran P. O’Connor, et al.. (2017). Dysregulated mitogen‐activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney. The Journal of Pathology. 244(3). 334–345. 8 indexed citations
10.
Finucane, Orla M., Claire L. Lyons, Aoife M. Murphy, et al.. (2015). Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity. Diabetes. 64(6). 2116–2128. 233 indexed citations
11.
Klinger, Rut, et al.. (2014). Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture. Cancer Cell International. 14(1). 108–108. 29 indexed citations
12.
Mulrane, Laoighse, Rut Klinger, Sharon F. McGee, William M. Gallagher, & Darran P. O’Connor. (2014). microRNAs: a new class of breast cancer biomarkers. Expert Review of Molecular Diagnostics. 14(3). 347–363. 36 indexed citations
13.
Brennan, Donal J., Rut Klinger, Fredrik Pontén, et al.. (2012). Abstract LB-444: SATB2 is a novel prognostic factor in colorectal cancer. Cancer Research. 72(8_Supplement). LB–444. 1 indexed citations
14.
Wolanin, Kamila, Adriana Magalska, Grażyna Mosieniak, et al.. (2006). Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells. Molecular Cancer Research. 4(7). 457–469. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026